GIADA TISCI

PhD Student

PhD program:: XXXVII
email: giada.tisci@uniroma1.it
phone: 0649910938
building: CU027
room: S23

supervisor: Falvo Elisabetta
co-supervisor: Boffi Alberto

Research: Human ferritins engineered for selective drug delivery

The main objective of the research project in which I am involved is to design, implement and characterize genetic mutants of human ferritin to be used in the selective transport of drugs. These new drug-delivery systems will be usable in various pathologies, such as cancer and neurodegenerative diseases.

November 2021- exp. November 2024: PhD in Biochemistry, XXXVII cycle- Sapienza University.

October 2019- July 2021: Master Degree in "Genomic Biotechnology”: Thesis :" Human ferritin engineered with Coronavirus Epitopes" Sapienza University. 110 e L/ 110.

Research products

11573/1699189 - 2023 - Widespread in vivo efficacy of The-0504: a conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers

Fracasso, Giulio; Falvo, Elisabetta; Tisci, Giada; Sala, Gianluca; Colotti, Gianni; Cingarlini, Sara; Tito, Claudia; Bibbò, Sandra; Frusteri, Cristina; Tremante, Elisa; Giordani, Elena; Giacomini, Patrizio; Ceci, Pierpaolo - 01a Articolo in rivista

paper: HELIYON (United Kingdom: Elsevier Limited) pp. 1-12 - issn: 2405-8440 - wos: WOS:001110406400001 (0) - scopus: 2-s2.0-85173325195 (1)

11573/1596700 - 2021 - Mitoxantrone-loaded nanoferritin slows tumor growth and improves the overall survival rate in a subcutaneous pancreatic cancer mouse model

Conti, G.; Pitea, M.; Ossanna, R.; Opri, R.; Tisci, G.; Falvo, E.; Innamorati, G.; Ghanem, E.; Sbarbati, A.; Ceci, P.; Fracasso, G. - 01a Articolo in rivista

paper: BIOMEDICINES (Basel : MDPI) pp. 1622- - issn: 2227-9059 - wos: WOS:000725043400001 (2) - scopus: 2-s2.0-85119580812 (2)